These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2284229)

  • 1. Putrescine has anti-arrhythmic effects in rat models of arrhythmia.
    Tagliavini S; Bazzani C; Genedani S; Vergoni AV; Bertolini A
    Pharmacol Res; 1990; 22 Suppl 1():125-6. PubMed ID: 2284229
    [No Abstract]   [Full Text] [Related]  

  • 2. Putrescine reverses aconitine-induced arrhythmia in rats.
    Bazzani C; Genedani S; Tagliavini S; Bertolini A
    J Pharm Pharmacol; 1989 Sep; 41(9):651-3. PubMed ID: 2573715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia- and reperfusion-induced arrhythmias are prevented by putrescine.
    Tagliavini S; Genedani S; Bertolini A; Bazzani C
    Eur J Pharmacol; 1991 Feb; 194(1):7-10. PubMed ID: 2060593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac arrhythmias, anti-arrhythmic drugs and prostaglandins.
    Das UN
    J Indian Med Assoc; 1980 Jan; 74(1):23-4. PubMed ID: 7229395
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
    Vos MA; Crijns HJ
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):27-34. PubMed ID: 12122969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection and combination of anti-arrhythmic agents].
    Fabregat JR
    Arch Inst Cardiol Mex; 1990; 60(5):479-84. PubMed ID: 2091552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
    Fujiki A
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myocardial model arrhythmias and anti-arrhythmic principles].
    Buntenkötter S
    Dtsch Tierarztl Wochenschr; 1978 Jun; 85(6):260-5. PubMed ID: 350552
    [No Abstract]   [Full Text] [Related]  

  • 9. Ambulatory monitoring of ECG and footfall in the investigation of arrhythmias and the assessment of anti-arrhythmic therapy [proceedings].
    Banks DC; Edwards B; Fentem PH; Hampton JR; Roland JM
    Br J Clin Pharmacol; 1978 Nov; 6(5):468P. PubMed ID: 728316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-arrhythmic effect of indomethacin in experimental studies].
    Sambelian VM; Krasnikov NF; Malakian MG
    Kardiologiia; 1988 Feb; 28(2):88-90. PubMed ID: 3373956
    [No Abstract]   [Full Text] [Related]  

  • 11. [The anti-arrhythmic effects and electrophysiological actions of propafenone].
    Zheng DS; Wang BY
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):418-20. PubMed ID: 3938327
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrically induced arrhythmias in the rat.
    Walker MJ; Beatch GN
    Proc West Pharmacol Soc; 1988; 31():167-70. PubMed ID: 3211899
    [No Abstract]   [Full Text] [Related]  

  • 13. [The research practice of anti-arrhythmic agents targeting on potassium ion channel].
    Yang Q; Wang XJ; Tang YQ; You QD
    Yao Xue Xue Bao; 2011 Jan; 46(1):12-8. PubMed ID: 21465803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute non-invasive test in the selection of anti-arrhythmic drugs. Preliminary study].
    de Berrazueta JR; Poveda J; Sánchez A; Ortiz de Murúa JA; Villarroel MT
    Med Clin (Barc); 1985 Jan; 84(2):54-7. PubMed ID: 3974348
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin.
    James MA; Jones JV
    Br J Clin Pharmacol; 1991 Sep; 32(3):375-8. PubMed ID: 1685666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmic agents. 1. anti-arrhythmic agents, indications, counter-indications side effects; dosage, methods of application; differential therapy].
    Weiss-Simon C; Spangenberg G; Michel D
    Fortschr Med; 1980 Apr; 98(14):519-25. PubMed ID: 7372249
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma drug concentration and cardiac function in arrhythmic patients during continuous drip of changrolin].
    Xu JM; Yin XL; Chen YM; Qi HM; Li CF; Shen LY; Chen WZ; Wang CG
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):227-31. PubMed ID: 2959017
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-arrhythmic effects of morlincain].
    Zhang YL; Rui YC; Tu SZ
    Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):417-20. PubMed ID: 3450178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-arrhythmic effect of changrolin combined with nicotinamide in experimental arrhythmia].
    Gu CG; Chen WZ; Dong YL; Ding GS
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):173-7. PubMed ID: 6239508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)].
    Chen JC; Min Y; Pan XX
    Zhongguo Yao Li Xue Bao; 1988 Mar; 9(2):132-6. PubMed ID: 3188948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.